MaxCyte MXCT Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by MaxCyte in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about MaxCyte's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MaxCyte's accretion (amortization) of discounts and premiums, investments?
- MaxCyte (MXCT) reported accretion (amortization) of discounts and premiums, investments of $437K in Q1 2026.
- How has MaxCyte's accretion (amortization) of discounts and premiums, investments changed year-over-year?
- MaxCyte's accretion (amortization) of discounts and premiums, investments decreased by 50.6% year-over-year, from $884K to $437K.
- What is the long-term trend for MaxCyte's accretion (amortization) of discounts and premiums, investments?
- Over 4 years (2021 to 2025), MaxCyte's accretion (amortization) of discounts and premiums, investments has grown at a 147.7% compound annual growth rate (CAGR), from $70.3K to $2.65M.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to the carrying value of investment securities to account for the amortization of premiums or the accretion of discounts over the life of the instrument. It reconciles the difference between the purchase price of an investment and its face value, ensuring interest income is recognized effectively. This metric provides insight into the company's treasury management and the yield characteristics of its investment portfolio.